Table 2.
Estimated absorbed doses (mGy/MBq) of [177Lu]-DO3A-VS-Cys40-Exendin-4 in human females and males extrapolated from rat organ distribution data
| ORGAN | FEMALE | MALE |
|---|---|---|
| Kidneys | 5.880 | 6.040 |
| Adrenals | 0.051 | 0.041 |
| Liver | 0.053 | 0.026 |
| LLI wall* | 0.071 | 0.049 |
| ULI wall** | 0.075 | 0.052 |
| Red marrow | 0.117 | 0.081 |
| Spleen | 0.058 | 0.036 |
| Osteogenic cells | 0.484 | 0.303 |
| Small intestine | 0.093 | 0.065 |
| Ovaries/Testes | 0.031 | 0.007 |
| Urinary Bladder Wall | 0.071 | 0.050 |
| Breasts | 0.068 | NA |
| Uterus | 0.071 | NA |
| Stomach wall | 0.076 | 0.053 |
| Thymus | 0.071 | 0.049 |
| Thyroid | 0.068 | 0.047 |
| Gall bladder wall | 0.078 | 0.056 |
| Skin | 0.066 | 0.045 |
| Lungs | 0.752 | 0.676 |
| Heart wall | 0.018 | 0.013 |
| Muscle | 0.013 | 0.009 |
| Pancreas | 0.067 | 0.051 |
| Brain | 0.069 | 0.047 |
| Total body | 0.119 | 0.088 |
| Total effective dose (mSv/MBq) | 0.295 | 0.265 |
LLI: lower large intestine;
ULI: upper large intestine.